Ministerial visit to Ukraine focused on health care and situation for women - Government.se

The Right Honourable Ed Miliband, Excellencies, dear colleagues and friends, I thank the United Kingdom, Qatar and Jordan for convening this important discussion on humanitarian access and health in Gaza. The situation in Gaza remains a humanitarian and public health emergency. The health system remains under extreme strain. Only 19 of Gaza's 36 hospitals are functioning even partially, and none fully functioning. Essential medicines, diagnostics, equipment and fuel remain in critically short supply. The result is patients with cancer who cannot receive treatment. People with kidney disease who cannot access regular dialysis. Mothers and newborns who face increased risks because health facilities lack medicines, equipment and specialist staff. And thousands have suffered amputations and life-long injuries. Yet only a small proportion have received prosthetic services, and rehabilitation capacity remains critically constrained. Approximately 1.7 million people remain displaced. Most are living in overcrowded conditions with inadequate shelter, water and sanitation, increasing the risk of disease outbreaks.

IntroductionHow does the gut microbiome change as we age? The link between gut microbiome changes and inflammationGut microbiome and age-related health conditionsCan the gut microbiome be targeted to promote longevity? From microbial shifts in later life to the distinctive gut communities of centenarians, researchers are investigating what the intestinal microbes reveal about how people age.

IntroductionClinical trial evidenceFDA approval and regulatory developmentsCardiometabolic and secondary benefitsFuture directionsReferences What can treatments targeting weight and metabolism offer people with obstructive sleep apnea, and which questions must clinical trials still answer?

A common liver disease affecting nearly 30% of adults worldwide is far more complex than previously understood. Researchers at Mayo Clinic have identified five biologically distinct forms of the condition, each associated with different risks of serious health complications, including heart disease, liver failure, cancer, and the need for a liver transplant. The findings, published in Nature Communications, come from a collaboration between Mayo Clinic and Virginia Tech. Scientists discovered that metabolic dysfunction-associated steatotic liver disease, or MASLD, can develop through several different biological pathways. Some are closely connected to obesity and diabetes, while others appear to be driven by inherited genetic differences.

IntroductionHypertension is a major global health concern and a leading cause of morbidity and mortality [1]. It is estimated that more than 19 million annual deaths are attributed to cardiovascular disease (CVD) worldwide [2]. In Japan, high blood pressure (BP) has been consistently identified as a strong risk factor for the national burden of CVD, in terms of notable incidence, mortality, direct/indirect healthcare costs, and quality-adjusted life years (QALYs) associated with this condition [3, 4]. Although age-specific mean BP declined in Japan over recent decades [5], hypertension remains a critical public health issue, particularly because of the rapid aging population. The proportion of individuals aged ≥65 years is projected to reach approximately 35% by 2040 in Japan [6], highlighting a potentially higher future burden of hypertension in this country. While the prevalence of hypertension increases with age, population aging may offset the benefits of declining BP levels in each age group. As a result, the future burden of hypertension in Japan remains uncertain.